Novel 2-arylthiazole derivatives of Formula I are described which are openers of KCNQ potassium channels and are useful in the treatment of disorders that are responsive to the opening of the KCNQ potassium channels, including pain and migraine.
1
公式I的新型2-芳基
噻唑衍
生物被描述为KC NQ
钾通道的开启剂,并且在治疗对KC NQ
钾通道的开启有响应的疾病,包括疼痛和偏头痛方面具有用处。